Medicskin Holdings Limited released a positive profit alert for the fiscal year ended 31 March 2026, indicating an expected consolidated profit attributable to shareholders of HK$0.50–1.50 million. The guidance marks a reversal from the HK$3.40 million net loss reported for FY2025.

Management attributes the anticipated turnaround to two main factors:

1. Revenue Growth • Higher demand for treatment services boosted the client base and increased visit frequency, lifting overall revenue.

2. Cost Optimisation • Lower rental expenses reduced depreciation of right-of-use assets. • Streamlined staffing levels trimmed personnel costs.

The profit range is derived from unaudited management accounts; final audited results are scheduled for release on 22 June 2026. Investors are urged to exercise caution when dealing in Medicskin shares until the audited figures are announced.